Hankook Tire & Technology has expanded its strategic partnership to provide original equipment manufacturer (OEM) tires to around 320 car models for 46 global carmakers, including Porsche, Mercedes-Benz, BMW, and Audi.
Thus, it is stepping up efforts to secure tire manufacturing source technology based on its innovative R&D strategy.
Based on its technological capability, Hankook, one of the largest tiremakers in the global market, built a portfolio covering all vehicle segments: from high-performance sports models to electric vehicle (EV) brands and pickup trucks.
The firm noted that its business portfolio was achieved through its R&D facility, Hankook Technodome.
Hankook Tire is supplying new tires for German carmaker Porsche's Cayenne and Macan SUVs and 718 Boxster high-performance roadster.
A variety of high-performance Audi models, such as RS Q8, RS7 Sportback, the RS4 Avant, the RS5 Coupe, the Q8, and the SQ8 TDI are using Hankook's tires.
Meanwhile, BMW's high-performance lineup of X3 M, X4 M, sedan 7 Series, and the M4 GT4 motorsport car use Hankook Tire's products as well.
The South Korean tiremaker also supplies Mercedes-Benz's SUVs, GLC and GLC Coupe, as well as Mini's JCW GP3.
EV maker Tesla, Italian brand Fiat, US brand GM, Chinese EV maker Nio, and Malaysia's Perodua are the tiremaker's non-German clients.


Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Asian Currencies Trade Flat as Dollar Weakens in Thin New Year Trading
Citi Forecasts a Volatile but Ongoing Bull Market for S&P 500 in 2026
Asian Markets End Year on AI Optimism as Precious Metals and Currencies Shine
South Korea Factory Activity Returns to Growth in December on Export Rebound
U.S. Dollar Steadies Ahead of Fed Minutes as Markets Eye Policy Divisions
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Oil Prices Slip Slightly as Markets Weigh Geopolitical Risks and Supply Glut Concerns
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
China Imposes 55% Tariff on Beef Imports Above Quota to Protect Domestic Industry
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 



